HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
Pharmacologic Treatments for COVID-19

During corona virus, the FDA has issued an emergency use authorization (EUA) for bamlanivimab, which is a monoclonal antibody given against the spike protein of SARS-CoV-2

Baricitinib or JAK inhibitor is used in combination with remdesivir, in the treatment of suspected or laboratory-confirmed coronavirus disease in hospitalized patients aged 2 years and elderly who require supplemental oxygen, invasive mechanical ventilation. Various other antiviral agents, immunotherapies, and vaccines continue to be investigated and developed as possible therapies.

Committee Members
Organizing committee member for Pharmaceutical Conferences 2021 - Sergey Suchkov

Sergey Suchkov

Sechenov University and Moscow Engineering Physical Institute, Russia
Organizing committee member for Drug Delivery Conferences - Esmaiel Jabbari

Esmaiel Jabbari

University of South Carolina, USA
Keynote speaker for Pharma conference 2021 - Marino Nebuloni

Marino Nebuloni

Parma University, Italy
Organizing committee member for Drug Delivery Conferences 2021 - Daniela Monti

Daniela Monti

University of Pisa, Italy
2021 Speakers
Potential Speaker for Pharma Conference 2021 - Jan Versijpt

Jan Versijpt

University Hospital Brussels, Belgium
Leading Speaker for pharmaceutical conferences 2021 - Madhav Bhatia

Madhav Bhatia

University of Otago, New zealand
Speaker for Pharma Conference 2021 - Stefanie Santos

Stefanie Santos

University Hospital Zurich, Switzerland
Eminent  Speaker for Drug Delivery Conferences 2021 - Dmitry Ustyuzhanin

Dmitry Ustyuzhanin

National Medical Research Center of Cardiology, Russia
Speaker for Drug Delivery Conferences - Anna Caprifico

Anna Caprifico

Kingston University, UK
Speaker for Pharma Conferences 2021 - Annalisa Dalmoro

Annalisa Dalmoro

University of Salerno, Italy

Submit your abstract Today